Childhood Obesity, Diabetes. and Cardiovascular Disease Risk

J Clin Endocrinol Metab. 2023 Nov 17;108(12):3051-3066. doi: 10.1210/clinem/dgad361.

Abstract

This mini-review aims to briefly summarize the pathophysiology of childhood obesity, type 2 diabetes mellitus (T2DM), and cardiovascular disease (CVD) risk in children and adolescents. Recent data on efficacy of lifestyle interventions, medications, and metabolic surgery for obesity, T2DM, and CVD risk factors are also reviewed. We conducted a PubMed search of English-language original and review articles relevant to childhood obesity, T2DM, and CVD risk factors, and biomarkers in children with an emphasis on recent publications. Childhood obesity arises from an intricate interaction between genetic, physiologic, environmental, and socioeconomic factors. The rise in the prevalence of childhood obesity is associated with the development of comorbidities including T2DM and CVD at an early age. A multipronged approach is central to the detection, monitoring, and management of childhood obesity and associated adverse metabolic consequences.

Keywords: cardiovascular; childhood obesity; diabetes; pathophysiology; treatment.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Cardiovascular Diseases* / complications
  • Cardiovascular Diseases* / etiology
  • Child
  • Comorbidity
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / etiology
  • Humans
  • Pediatric Obesity* / complications
  • Pediatric Obesity* / epidemiology
  • Risk Factors